Upgrade: Phase 1 trial of the NaPi2b-directed dolaflexin antibody drug conjugate UpRi in combination with carboplatin in patients with platinum-sensitive ovarian cancer (PSOC) Meeting Abstract
| Authors: | Friedman, C.; Anderson, C.; Hays, J.; Lakhani, N.; Buscema, J.; Hamilton, E.; Taylor, S.; Duska, L.; Cloven, N.; Reske, A.; Bradshaw, C.; Sumrow, B.; Werner, T. |
| Abstract Title: | Upgrade: Phase 1 trial of the NaPi2b-directed dolaflexin antibody drug conjugate UpRi in combination with carboplatin in patients with platinum-sensitive ovarian cancer (PSOC) |
| Meeting Title: | IGCS 2024 Annual Meeting |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 34 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2024 Oct 16-18 |
| Meeting Location: | Dublin, Ireland |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2024-10-01 |
| Start Page: | A216 |
| Language: | English |
| ACCESSION: | WOS:001443871900029 |
| DOI: | 10.1136/ijgc-2024-IGCS.376 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract : EV257/#1106 -- Source: Wos |
